Esketamine's Role in Postoperative Care for Elderly CRC Patients

Introduction to Esketamine in Postoperative Care

A recent randomized controlled trial has highlighted the potential of esketamine to significantly reduce postoperative depression and anxiety in elderly colorectal cancer (CRC) patients. This study, published on April 21, 2026, in an unknown venue, underscores the psychological benefits of esketamine when used alongside sufentanil, a commonly used opioid analgesic.

Mechanism and Study Context

Elderly CRC patients often experience high rates of postoperative depression, a condition inadequately managed by traditional opioid-based analgesia. Esketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist known for its rapid antidepressant effects, was tested in this population for the first time. The trial involved 99 elderly patients undergoing CRC resection, divided into three groups: a control group receiving sufentanil with a saline placebo, and two experimental groups receiving sufentanil with either 1 mg/kg or 2 mg/kg of esketamine.

Research Implications and Findings

The study's primary outcomes focused on anxiety and depression levels, measured by the Hamilton Anxiety Rating Scale (HAMA) and Hamilton Depression Rating Scale (HAMD) at 24 and 72 hours postoperatively. Both esketamine groups demonstrated significantly lower scores compared to the control group, indicating reduced depression and anxiety without dose-dependent differences. Secondary outcomes such as pain scores and patient satisfaction also favored the esketamine groups, with no increase in adverse events.

Risks and Unknowns

While the trial results are promising, the long-term effects of esketamine use in this context remain unknown. The study did not find any differences in pain control or adverse events between the groups, suggesting that esketamine does not enhance analgesia. However, its psychological benefits could justify its inclusion in postoperative care protocols, particularly for vulnerable elderly patients.

Future Directions and Policy Considerations

The findings suggest that integrating esketamine into enhanced recovery protocols could improve postoperative outcomes for elderly CRC patients. Policymakers and healthcare providers should consider these results when developing guidelines for postoperative care. Further research is needed to explore the long-term effects and potential applications of esketamine in other surgical populations.